- Anticonvulsants General Statement 28:12 (Revision, May 3, 2013)
- Antivenin (Micrurus fulvius) (Equine) 80:04 (Revision, April 22, 2013)
- Azithromycin 8:12.12.92 (Revised, March 20, 2013)
- Benzodiazepines General Statement 28:24.08 (Revision, May 2, 2013)
- Carglumic Acid (New monograph, May 1, 2013)
- Cinacalcet 92:92 (Revision, February 26, 2013)
- Clobazam 28:12.92 (New monograph, April 24, 2013)
- Exenatide 68:20.06 (Revised, March 20, 2013)
- Factor XIII 20:28.16 (New monograph, April 24, 2013)
- Ibuprofen 28:08.04.92 (Revision, April 23, 2013)
|
|
- Linagliptin 68:20.05 (Revised, March 20, 2013)
- Liraglutide 68:20.06 (Revised, March 20, 2013)
- Lisinopril 24:32.04 (Revision, April 23, 2013)
- Nesiritide 24:12.92 (Revision, May 3, 2013)
- Saxagliptin 68:20.05 (Revised, March 20, 2013)
- Sitagliptin 68:20.05 (Revised, March 20, 2013)
- Tolvaptan 40:28.28 (Revision, April 30, 2013)
- Trastuzumab 10:00 (Revision, April 26, 2013)
- Valproate Sodium 28:12.92 (Revision, May 6, 2013)
|